LAST CHANCE – Expires November 21!

Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.

Listen now and earn 0.5 CME credit: bit.ly/49GyP5T

Time is running out to access this essential CME/NCPD-approved podcast! Join renowned dermatology experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold as they dive into the latest evidence and best practices for treating atopic dermatitis in children and adolescents. With new therapies rapidly changing the treatment landscape, this podcast delivers the practical insights you need to confidently diagnose, evaluate, and manage pediatric atopic dermatitis.

Don’t miss your chance to:

-Get up to speed on novel and emerging therapies, including nonsteroidal topicals, JAK inhibitors, and monoclonal antibodies

-Learn how to recognize key clinical features that inform the differential diagnosis

-Discover strategies to optimize outcomes and quality of life for your young patients

This activity is expiring soon—listen now to stay current and earn credit before it’s gone!

Click here to claim your CME/NCPD credit: https://bit.ly/4nGZhBG

Christoph U. Correll, MD, Professor of Psychiatry and Molecular Medicine at the Zucker School of Medicine at Hofstra/Northwell and Chair of Child and Adolescent Psychiatry at Charité University in Berlin, is currently chairing i3 Health’s four-part educational activity, Schizophrenia Update: Navigating the Latest in Research and Treatment. In this interview, he shares recent updates in schizophrenia research and explains why education is so critical for clinicians to optimize their patients’ outcomes.

Click here to listen to the full activity podcasts! 

Module 1: https://bit.ly/3JsEYKf

Module 2: https://bit.ly/436dYa5

Module 3: https://bit.ly/47fkz4p

Module 4: https://bit.ly/4oflWWZ

Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care, including new drug approvals, multidisciplinary approaches, and crucial diagnostic updates. Learn how to shorten diagnosis times and improve long-term patient quality of life. Stay tuned after the interview to hear Module 2 of the podcast series, "Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies"

Don't forget to claim your credit after the episode!

Click on the link to claim your credit for module 2: bit.ly/43VoFNP

Stay ahead in Systemic Mastocytosis (SM) treatment! This interview, featuring Dr. Mariana Castells, explores the latest advancements in patient-centered care, including new drug approvals, multidisciplinary approaches, and crucial diagnostic updates. Learn how to shorten diagnosis times and improve long-term patient quality of life. Stay tuned after the interview to hear Module 1 of the podcast series, "Mastering Systemic Mastocytosis: From Early Detection to Tailored Treatment Strategies"

Don't forget to claim your credit after the episode!

Click on the link to claim your credit for module 1: bit.ly/3Y3ivHM

Click here to continue listening to Module 2 of this podcast series: bit.ly/43VoFNP

Psoriatic arthritis care is rapidly evolving, demanding multidisciplinary collaboration and timely access to evidence-based therapies for optimal patient outcomes. i3 Health's Multidisciplinary Task Force—Increasing Early Intervention and Optimizing Management in Psoriatic Arthritis—convened expert clinicians and a patient moderator to address real-world challenges in screening, diagnosis, comorbidity management, and therapeutic optimization.

In this follow-up interview, Archie Franklin, MBA, a psoriatic arthritis patient and Task Force moderator, shares insights on the discussion, the changing treatment landscape, and practical guidance for elevating standards of care.

Click here to view the Task Force and claim your CE credit: https://bit.ly/4h5NSKb

Transform your approach to CLL care with insights from clinical pharmacy expert, "Kelsey Marciano, PharmD, BCOP,UCHealth. This podcast unpacks the latest strategies for treatment selection and toxicity management—empowering oncology pharmacists to lead confidently, maximize patient outcomes, and deliver next-level care in the evolving era of oral targeted therapies.

🎧 Listen now and click the link to claim your CE credit!

Claim your credit here: https://bit.ly/4pGrLO5

🔗 Learn more and access continuing education activities: https://i3health.com

📲 Stay connected with i3 Health:

Twitter/X: https://bit.ly/42VAYs1

LinkedIn: https://bit.ly/3IMiCmv

Facebook: https://bit.ly/46JrQI2

YouTube: https://bit.ly/4pNhWxR

Instagram: https://bit.ly/4nUSNzE

Threads: https://bit.ly/3Wd6oq9

🎧 Subscribe to the i3 Health Podcast on your favorite streaming platform so you never miss the latest expert discussions!

Extrapulmonary neuroendocrine carcinomas (EP-NECs) are rare, aggressive tumors that present unique diagnostic and treatment challenges. In this accredited activity podcast, leading experts Dr. Andrew E. Hendifar and Dr. Danielle Hutchings from Cedars-Sinai Medical Center share practical strategies and emerging evidence on diagnosis, current therapies, and novel treatment targets.

Listen now to gain actionable insights and stay current on evolving approaches in EP-NECs!

Click the link to claim your CE credit: https://bit.ly/488fPhK

Last Chance: Multiple Myeloma Task Force Podcast

Don't miss your final opportunity to listen to this CME/NCPD-accredited podcast on Multidisciplinary Task Force and Position Statement: Mitigating Disease Burden and Healthcare Disparities in Relapsed/Refractory Multiple Myeloma. Last chance to listen and claim credit is September 10, 2025.

Hear from Task Force Co-Chairs Dr. Sikander Ailawadhi (Mayo Clinic) and Dr. Rahul Banerjee (Fred Hutchinson Cancer Center/University of Washington) as they discuss strategies for improving patient outcomes and addressing healthcare disparities in relapsed/refractory multiple myeloma.

Click here to claim your CME/NCPD credit: https://bit.ly/4e25pQP

Esophagogastric Cancer: Enhancing Outcomes Through Biomarkers and Collaborative Care is an accredited, two-part series led by expert Yelena Y. Janjigian, MD.

Building on the foundation of biomarker-driven care, this module focuses on optimizing treatment strategies for patients with esophagogastric cancer. Dr. Janjigian reviews the latest evidence on targeted therapies, immunotherapies, and combination regimens, as well as practical considerations for sequencing and selecting therapies. Gain actionable insights to enhance collaborative care and deliver the most effective, individualized treatment plans for your patients. Listen now!

Click here to claim credit for this activity: bit.ly/3HtOziO

Click here to listen to Module 1 of this series: bit.ly/45u106o